Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease.
2024
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
5-Aminosalicylic acid in the treatment of inflammatory bowel disease.
January 1987, Acta medica Scandinavica,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
5-Aminosalicylic acid for the treatment of inflammatory bowel disease.
August 1984, Gastroenterology,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease.
March 2023, Nature medicine,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease.
July 1989, Gastroenterology,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease.
January 1989, Drugs,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease.
July 2011, Therapeutic advances in gastroenterology,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease.
September 2000, Alimentary pharmacology & therapeutics,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
[Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
January 1995, Gastroenterologia y hepatologia,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
[5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease].
January 1986, Leber, Magen, Darm,
Naomi Karmi, and Shiqiang Sun, and Eleonora A M Festen, and Arnau Vich Vila, and Ranko Gacesa, and Rinse K Weersma
Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
December 1987, Digestive diseases and sciences,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name